✦ LIBER ✦
In CML Patients, Residual Disease In Primitive Stem/Progenitor Cells Following Allogeneic Stem Cell Transplantation Is Higher Than After Treatment With Tyrosine Kinase Inhibitors Alone, But Is Still Amenable To GVL Effects
✍ Scribed by A.S.M. Yong; K. Keyvanfar; R. Eniafe; B.N. Savani; K. Rezvani; A. Shenoy; E.K. Koklanaris; L. Musse; T. Donohue; Q. Le; J.M. Goldman; A.J. Barrett
- Book ID
- 116281289
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 69 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.